Difference between revisions of "Globalisation:National Obesity Forum"

From Powerbase
Jump to: navigation, search
(Sources)
(Trustees)
Line 20: Line 20:
 
==People==
 
==People==
  
===Trustees===
+
[[Trustees]]
 
 
*Dr [[Hilary Jones]] Patron
 
 
 
*[[Jane DeVille-Almond]] Vice Chair
 
 
 
*Dr [[David Haslam]] - GP, Hertfordshire Chair
 
 
 
*[[Shamil Chandaria]] - Honorary Patron
 
 
 
*[[Anne Diamond Honorary]] - Patron
 
 
 
*[[Debbie Cook]]
 
 
 
*Dr [[Matthew Capehorn]] - Clinical Director
 
 
 
*[[Tam Fry]] - Honorary Chairman of The Child Growth Foundation
 
 
 
*[[Paul Sacher]] - Research Director, MEND Programme
 
 
 
*Dr [[Colin Waine]] - Patron
 
 
 
*[[Graham Philips]]
 
 
 
[http://www.nationalobesityforum.org.uk/about-us/the-nof-trustees-mainmenu-159.html National Obesity Forum Trustees]
 
 
 
  
 
[[Funding]]
 
[[Funding]]
 
 
  
 
==Views on tackling obesity==
 
==Views on tackling obesity==

Revision as of 18:51, 19 October 2010

Emma Patrick Christina McDonald Rachel Cunningham

http://www.nationalobesityforum.org.uk/

History

The National Obesity Forum was created in 2000 by a group of health professionals and is a registered charity (1109600).

The main aims of the NOF are to:

-Increase the public focus on obesity and develop more awareness about the health implications.

-To help educate more people on the topic of obesity and health from an earlier age.

-To encourage the Government to make tackling obesity a priority, in order to save the NHS money in future years.

People

Trustees

Funding

Views on tackling obesity

The National Obesity Forum advocate many ways of tackling obesity.


-They advise increasing activity levels, and put importance on making exercise ‘fun’ and easy by focussing on ordinary activities such as gardening, shopping, and sports.

-They also advise making a personal plan to suit each individual.

-They provide information on how to have a healthy diet and put importance on portion control.

- Advice is also given on 'positive thinking' and how this can impact a person's ability to lose weight.


The NOF also back more drastic and often risky means of weight loss, including; very low calorie diets, medication, meal replacements, and even surgery.

With regards to weight loss medication (or 'Anti-Obesity Medication), the NOF mention two specific drugs - Sibutramine(Reductil) and Orlistat(Alli).

One of these drugs - Orlistat - was actually the first 'over the counter' weight loss drug available, and was produced by Glaxosmithkline, which is one of the NOFs parter organisations. [1]

Notes

  1. Orlistat, "Overweight and Obese Treatment - GlaxoSmithKline Receieves European Commission to Market Alli", Orlistat, 21 January 2009, accessed 19 October 2010